Xylem (XYL) PT Raised to $162 at RBC Capital
RBC Capital analyst Deane Dray raised the price target on Xylem (NYSE: XYL) to $162.00 (from $157.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
